Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis

We present a case of a 27-year-old man with recurrent episodes of angioedema since he was 19, who responded well to treatment with medical grade cannabis. Initially, he responded to steroids and antihistam...

Full description

Bibliographic Details
Main Authors: Amit Frenkel, Aviel Roy-Shapira, Brotfain Evgeni, Koyfman Leonid, Abraham Borer, Moti Klein
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Case Reports in Immunology
Online Access:http://dx.doi.org/10.1155/2015/780824
id doaj-8f9131ba96ac4cd19192051942dcd7a8
record_format Article
spelling doaj-8f9131ba96ac4cd19192051942dcd7a82020-11-24T21:04:40ZengHindawi LimitedCase Reports in Immunology2090-66092090-66172015-01-01201510.1155/2015/780824780824Life Threatening Idiopathic Recurrent Angioedema Responding to CannabisAmit Frenkel0Aviel Roy-Shapira1Brotfain Evgeni2Koyfman Leonid3Abraham Borer4Moti Klein5General Intensive Care Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beersheba, IsraelGeneral Intensive Care Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beersheba, IsraelGeneral Intensive Care Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beersheba, IsraelGeneral Intensive Care Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beersheba, IsraelInfection Control and Hospital Epidemiology Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beersheba, IsraelGeneral Intensive Care Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beersheba, IsraelWe present a case of a 27-year-old man with recurrent episodes of angioedema since he was 19, who responded well to treatment with medical grade cannabis. Initially, he responded to steroids and antihistamines, but several attempts to withdraw treatment resulted in recurrence. In the last few months before prescribing cannabis, the frequency and severity of the attacks worsened and included several presyncope events, associated with scrotal and neck swelling. No predisposing factors were identified, and extensive workup was negative. The patient reported that he was periodically using cannabis socially and that during these periods he was free of attacks. Recent data suggest that cannabis derivatives are involved in the control of mast cell activation. Consequently, we decided to try a course of inhaled cannabis as modulators of immune cell functions. The use of inhaled cannabis resulted in a complete response, and he has been free of symptoms for 2 years. An attempt to withhold the inhaled cannabis led to a recurrent attack within a week, and resuming cannabis maintained the remission, suggesting a cause and effect relationship.http://dx.doi.org/10.1155/2015/780824
collection DOAJ
language English
format Article
sources DOAJ
author Amit Frenkel
Aviel Roy-Shapira
Brotfain Evgeni
Koyfman Leonid
Abraham Borer
Moti Klein
spellingShingle Amit Frenkel
Aviel Roy-Shapira
Brotfain Evgeni
Koyfman Leonid
Abraham Borer
Moti Klein
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
Case Reports in Immunology
author_facet Amit Frenkel
Aviel Roy-Shapira
Brotfain Evgeni
Koyfman Leonid
Abraham Borer
Moti Klein
author_sort Amit Frenkel
title Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_short Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_full Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_fullStr Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_full_unstemmed Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
title_sort life threatening idiopathic recurrent angioedema responding to cannabis
publisher Hindawi Limited
series Case Reports in Immunology
issn 2090-6609
2090-6617
publishDate 2015-01-01
description We present a case of a 27-year-old man with recurrent episodes of angioedema since he was 19, who responded well to treatment with medical grade cannabis. Initially, he responded to steroids and antihistamines, but several attempts to withdraw treatment resulted in recurrence. In the last few months before prescribing cannabis, the frequency and severity of the attacks worsened and included several presyncope events, associated with scrotal and neck swelling. No predisposing factors were identified, and extensive workup was negative. The patient reported that he was periodically using cannabis socially and that during these periods he was free of attacks. Recent data suggest that cannabis derivatives are involved in the control of mast cell activation. Consequently, we decided to try a course of inhaled cannabis as modulators of immune cell functions. The use of inhaled cannabis resulted in a complete response, and he has been free of symptoms for 2 years. An attempt to withhold the inhaled cannabis led to a recurrent attack within a week, and resuming cannabis maintained the remission, suggesting a cause and effect relationship.
url http://dx.doi.org/10.1155/2015/780824
work_keys_str_mv AT amitfrenkel lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT avielroyshapira lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT brotfainevgeni lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT koyfmanleonid lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT abrahamborer lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
AT motiklein lifethreateningidiopathicrecurrentangioedemarespondingtocannabis
_version_ 1716770249822437376